Tags

Type your tag names separated by a space and hit enter

[First case of COVID-19 treated with tocilizumab in Iceland].
Laeknabladid. 2020 Mai; 106(5):247-250.L

Abstract

A gentleman in his early fifties became ill with flu-like symptoms after vacationing abroad and was diagnosed with COVID-19 after returning to Iceland. A few days later he was admitted to the University Hospital, Landspitali, due to worsening respiratory symptoms and severe fatigue. A computed tomography scan of lthe lungs showed diffuse bilateral consolidations and ground glass changes. He developed respiratory failure and was transferred to the intensive care unit where he received further treatment, including tocilizumab (IL-6 receptor inhibitor). He subsequently showed clinical improvement and did not require endotracheal intubation.

Authors+Show Affiliations

Landspítali University Hospital, Department of Medicine.Landspítali University Hospital, Department of Radiology.Landspítali University Hospital, Department of Anesthesia and Intensive Care.Landspítali University Hospital, Department of Infectious Diseases.Landspítali University Hospital, Department of Infectious Diseases.Landspítali University Hospital, department of immunology, University of Iceland, Faculty of Medicine.Landspítali University Hospital, Department of Infectious Diseases, University of Iceland, Faculty of Medicine.Landspítali University Hospital, Department of Infectious Diseases, University of Iceland, Faculty of Medicine.

Pub Type(s)

Case Reports
Journal Article

Language

ice

PubMed ID

32367812

Citation

Bjornsson, Aron Hjalti, et al. "[First Case of COVID-19 Treated With Tocilizumab in Iceland]." Laeknabladid, vol. 106, no. 5, 2020, pp. 247-250.
Bjornsson AH, Olafsdottir T, Thormar KM, et al. [First case of COVID-19 treated with tocilizumab in Iceland]. Laeknabladid. 2020;106(5):247-250.
Bjornsson, A. H., Olafsdottir, T., Thormar, K. M., Kristjansson, M., Thorisdottir, A. S., Ludviksson, B. R., Guðmundsson, S., & Gottfredsson, M. (2020). [First case of COVID-19 treated with tocilizumab in Iceland]. Laeknabladid, 106(5), 247-250. https://doi.org/10.17992/lbl.2020.05.581
Bjornsson AH, et al. [First Case of COVID-19 Treated With Tocilizumab in Iceland]. Laeknabladid. 2020 Mai;106(5):247-250. PubMed PMID: 32367812.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [First case of COVID-19 treated with tocilizumab in Iceland]. AU - Bjornsson,Aron Hjalti, AU - Olafsdottir,Thorbjorg, AU - Thormar,Katrin Maria, AU - Kristjansson,Mar, AU - Thorisdottir,Anna Sesselja, AU - Ludviksson,Bjorn Runar, AU - Guðmundsson,Sigurdur, AU - Gottfredsson,Magnus, PY - 2020/5/6/entrez PY - 2020/5/6/pubmed PY - 2020/5/7/medline KW - COVID-19 KW - Coronavirus KW - Cytokine storm KW - SARS-CoV-2 KW - Tocilizumab SP - 247 EP - 250 JF - Laeknabladid JO - Laeknabladid VL - 106 IS - 5 N2 - A gentleman in his early fifties became ill with flu-like symptoms after vacationing abroad and was diagnosed with COVID-19 after returning to Iceland. A few days later he was admitted to the University Hospital, Landspitali, due to worsening respiratory symptoms and severe fatigue. A computed tomography scan of lthe lungs showed diffuse bilateral consolidations and ground glass changes. He developed respiratory failure and was transferred to the intensive care unit where he received further treatment, including tocilizumab (IL-6 receptor inhibitor). He subsequently showed clinical improvement and did not require endotracheal intubation. SN - 1670-4959 UR - https://www.unboundmedicine.com/medline/citation/32367812/[First_case_of_COVID_19_treated_with_tocilizumab_in_Iceland]_ L2 - https://doi.org/10.17992/lbl.2020.05.581 DB - PRIME DP - Unbound Medicine ER -